Quantum-Si incorporated (QSI)
NASDAQ: QSI · Real-Time Price · USD
1.270
-0.060 (-4.51%)
Aug 8, 2025, 4:00 PM - Market closed

Company Description

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument.

It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results.

Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications.

Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.

Quantum-Si incorporated
Quantum-Si incorporated logo
CountryUnited States
Founded2013
IndustryMedical Devices
SectorHealthcare
Employees149
CEOJeffrey Hawkins

Contact Details

Address:
29 Business Park Drive
Branford, Connecticut 06405
United States
Phone866 688 7374
Websitequantum-si.com

Stock Details

Ticker SymbolQSI
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001816431
CUSIP Number74765K105
ISIN NumberUS74765K1051
Employer ID85-1388175
SIC Code3829

Key Executives

NamePosition
Jeffrey Alan HawkinsPresident, Chief Executive Officer and Director
Dr. Jonathan M. Rothberg Ph.D.Founder and Executive Director
Jeffry R. Keyes CPAChief Financial Officer and Treasurer
Todd C. BennettChief Commercial Officer
Todd RearickChief Technology Officer
Dr. Christian Lapointe J.D., Ph.D.General Counsel and Corporate Secretary
Lindsay ThompsonChief Human Resources Officer
Katherine AtkinsonSenior Vice President of Demand Generation and Corporate Brand
Dr. John S. Vieceli Ph.D.Chief Product Officer

Latest SEC Filings

DateTypeTitle
Aug 8, 20258-KCurrent Report
Aug 5, 202510-QQuarterly Report
Aug 5, 20258-KCurrent Report
Jul 29, 2025SCHEDULE 13GFiling
Jul 7, 20258-KCurrent Report
Jul 7, 2025424B5Filing
Jul 7, 2025424B5Filing
Jun 6, 2025SCHEDULE 13G/AFiling
May 22, 2025SDForm - SD
May 19, 20258-KCurrent Report